Literature DB >> 18711342

The syndrome of inappropriate secretion of antidiuretic hormone associated with SCT: clinical differences following SCT using cord blood and BM/peripheral blood.

Y Suzuki1, R Kobayashi, A Iguchi, T Sato, M Kaneda, K Kobayashi, T Ariga.   

Abstract

Previously, we reported the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) as an underestimated complication associated with SCT. In the present report, we analyzed detailed data on a larger number of patients with SIADH following SCT and found different SIADH clinical features following cord blood SCT (CBSCT) and BMT/PBSCT. The median onset of SIADH following CBSCT and BMT/PBSCT was 19 and 46 days after SCT, respectively, and the median numbers of WBC at the onset of SIADH were 1.0 and 3.1 x 10(9)/l, respectively. Furthermore, severe symptoms such as seizures, somnolence and rigidity of limbs were observed only in patients with CBSCT (8/15 vs 0/10). These differences were statistically significant (P<0.01). Although the precise basis for SIADH following SCT still remains unknown, the different features of SIADH observed following CBSCT and BMT/PBSCT may provide important clues to the disease mechanism following SCT. Additionally, we confirmed our previous results that patients with SIADH showed a higher overall survival and event-free survival rates. However, we first suggested that they had some neurological disorders and that neurological sequelae such as developmental delay and seizures would consequently occur.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18711342     DOI: 10.1038/bmt.2008.247

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  1 in total

1.  Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis.

Authors:  Koichi Murakami; Sumiko Kohashi; Masatoshi Sakurai; Jun Kato; Takaaki Toyama; Yuya Koda; Yusuke Yamane; Risa Hashida; Ryohei Abe; Rie Yamazaki; Taku Kikuchi; Takayuki Shimizu; Shigeaki Suzuki; Naoki Hasegawa; Shinichiro Okamoto; Takehiko Mori
Journal:  Int J Hematol       Date:  2017-05-13       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.